Issue · Healthcare

Healthcare (Prescription Drugs)

Every healthcare bill, vote, and legislator stance in Virginia, automatically classified by Maddy, our AI policy reader.

Total bills
32
2026 Regular Session
Top supporter
Irene Shin
100% support rate
Top opponent
Bill DeSteph
0% support rate
Ranked legislators
10
5 support · 5 oppose
Key legislators

Who's moving prescription drugs in Virginia

Legislators moving prescription drugs in Virginia
Legislator Party Stance Support rate Decisive votes
Irene Shin
Irene Shin House · District 8
D
Strong +
100% 23
Aaron Rouse
Aaron Rouse Senate · District 22
D
Strong +
100% 20
Creigh Deeds
Creigh Deeds Senate · District 11
D
Strong +
100% 20
Jeremy McPike
Jeremy McPike Senate · District 29
D
Strong +
100% 20
Louise Lucas
Louise Lucas Senate · District 18
D
Strong +
100% 20
Bill DeSteph
Bill DeSteph Senate · District 20
R
Strong −
0% 16
Bill Wiley
Bill Wiley House · District 32
R
Strong −
0% 10
Phil Scott
Phil Scott House · District 63
R
Strong −
0% 10
Christie Craig
Christie Craig Senate · District 19
R
Strong −
0% 9
Eric Zehr
Eric Zehr House · District 51
R
Strong −
0% 8
Showing 31–32 of 32 bills

All healthcare bills

vetoed · Virginia · House of Delegates Apr 13, 2026

HB 1450: Health insurance; claims experience information.

Health insurance; claims experience information. Provides that provisions requiring insurers to provide policyholders with certain claims experience information apply to all employee welfare benefit plans and include pharmacy benefits claims.
signed · Virginia · House of Delegates Apr 8, 2026

HB 795: Health insurance; requirements for certain opioid antagonists.

Health insurance; requirements for certain opioid antagonists. Requires each health insurer, corporation providing health care subscription plans, and health maintenance organization whose policy, contract, or plan includes coverage for prescription drugs to include coverage for at least one other opioid antagonist used for overdose reversal dispensed pursuant to an oral, written, or standing order of a prescriber and ensure that cost-sharing for at least one opioid antagonist used for overdose reversal is included on the lowest cost tier of the insurer's, corporation's, or health maintenance organization's prescription drug formulary. The bill provides that such coverage shall be exempt from any prior authorization or step therapy requirement on coverage of benefits. As introduced, this bill was a recommendation of the Joint Commission on Health Care. This bill is identical to SB 257.
Showing 31 to 32 of 32 bills
Previous 1 … 2 3 4